Here are what the editors at HealthDay consider to be the most important developments in Surgery for September 2018. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice.
Physicians Often Don’t Address Their Burnout
FRIDAY, Sept. 28, 2018 (HealthDay News) — More than half of physicians experience burnout, and many do not seek treatment for burnout, according to a report published in the American Medical Association’s AMA Wire.
Surgical Mesh Itself Not Tied to Increased Complications
FRIDAY, Sept. 28, 2018 (HealthDay News) — Use of mesh is not independently associated with an increase in the rate of complications of pelvic organ prolapse repair, according to a study published in the August issue of The Journal of Urology.
No Benefit to Negative Pressure Wound Therapy After C-Section
FRIDAY, Sept. 28, 2018 (HealthDay News) — For obese women, use of prophylactic negative pressure wound therapy versus standard dressings does not reduce superficial surgical site infections after cesarean section, according to a study published in the August issue of Obstetrics & Gynecology.
Business Degree Increasingly Useful for Doctors
THURSDAY, Sept. 27, 2018 (HealthDay News) — Having a Master of Business Administration degree (M.B.A.) can help doctors with important, practice-related decisions, according to a report published recently in Physician Practice.
Kidney Function Recovery Seen in Some Children on Dialysis
THURSDAY, Sept. 27, 2018 (HealthDay News) — Roughly 2 percent of pediatric patients on maintenance dialysis recover within two years after dialysis initiation, according to a study published online Sept. 20 in the Clinical Journal of the American Society of Nephrology.
Practices Should Set Rules for Staff Social Media Use
THURSDAY, Sept. 27, 2018 (HealthDay News) — Medical practices can take steps to avoid problems related to use of social media by staff members, according to an article published in Medical Economics.
PCI, CABG Both Acceptable for CKD Patients With LMCAD
WEDNESDAY, Sept. 26, 2018 (HealthDay News) — For patients with left main coronary artery disease (LMCAD), those with and without chronic kidney disease (CKD) undergoing revascularization have similar long-term outcomes with percutaneous coronary intervention (PCI) and coronary artery bypass grafting (CABG), according to a study published in the Aug. 14 issue of the Journal of the American College of Cardiology.
Burnout, Career Choice Regret Prevalent in U.S. Residents